Interaction of gentamicin polycation with model and cell membranes

Bioelectrochemistry

Volumn 87, Issue , 2012, Pages 230-235

  Kovács, Eugenia ^a   Savopol, Tudor ^a   Iordache, Maria Minodora ^a   Sǎplǎcan, Lavinia ^a   Sobaru, Iuliana ^a   Istrate, Claudia ^a   Mingeot Leclercq, Marie Paule ^b   Moisescu, Mihaela Georgeta ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Fluorescence anisotropy; Generalized polarization; Gentamicin; Liposomes; OK cell lines

Indexed keywords

ANTIBIOTIC GENTAMICIN; ARTIFICIAL BILAYER; CARDIOLIPINS; CELL LINES; CHARGE COMPOSITION; FLUORESCENCE ANISOTROPY; GENERALIZED POLARIZATION; GENTAMICIN; LABELED CELLS; LAURDAN; LIPOSOMAL MEMBRANES; LIVING CELL; LIVING CELL MEMBRANES; MEMBRANE HYDRATION; MEMBRANE LIPIDS; OPOSSUM KIDNEYS; P-TOLUENESULFONATES; POLYCATIONS; TRANSMEMBRANES;

ANISOTROPY; CELL CULTURE; CELL MEMBRANES; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; LIGHT POLARIZATION; LIPOSOMES; PHOSPHOLIPIDS;

MEMBRANES;

CALCIUM ION; CARDIOLIPIN; DIMYRISTOYLPHOSPHATIDYLCHOLINE; GENTAMICIN; LIPOSOME; MEMBRANE RECEPTOR; POLYCATION;

ANIMAL CELL; ANISOTROPY; ARTICLE; CELL MEMBRANE; CELL MEMBRANE DEPOLARIZATION; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; EUKARYOTIC CELL; FLUORESCENCE SPECTROSCOPY; HAIR CELL; KIDNEY TUBULE CELL; MEMBRANE CHANNEL; MEMBRANE STRUCTURE; NONHUMAN; OPOSSUM; TRANSITION TEMPERATURE;

2-NAPHTHYLAMINE; ANIMALS; BIOLOGICAL TRANSPORT; CARDIOLIPINS; CELL MEMBRANE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DIPHENYLHEXATRIENE; EPITHELIAL CELLS; FLUORESCENCE POLARIZATION; FLUORESCENT DYES; GENTAMICINS; KIDNEY; LAURATES; LIPOSOMES; MEMBRANE LIPIDS; MEMBRANES, ARTIFICIAL; OPOSSUMS; POLYAMINES; SPECTROMETRY, FLUORESCENCE; STATIC ELECTRICITY;

DIDELPHIDAE; EUKARYOTA;

EID: 84865186607     PISSN: 15675394     EISSN: 1878562X     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2012.03.001     Document Type: Article

References (47)

1. Myrdal S.E., Johnson K.C., Steyger P.S. Cytoplasmic and intra-nuclear binding of gentamicin does not require endocytosis. Hear. Res. 2005, 204:156-169.
2. Leehey D.J., Braun B.I., Tholl D.A., Chung L.S., Gross C.A., Roback J.A., Lentino J.R. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy. J. Am. Soc. Nephrol. 1993, 4:81-90.
3. Hock R., Anderson R.J. Prevention of drug-induced nephrotoxicity in the intensive care unit. J. Crit. Care 1995, 10:33-43.
4. van Lent-Evers N.A., Mathot R.A., Geus W.P., van Hout B.A., Vinks A.A. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis. Ther. Drug Monit. 1999, 21:63-73.
5. Rougier F., Claude D., Maurin M., Maire P. Aminoglycoside nephrotoxicity. Curr. Drug Targets Infect. Disord. 2004, 4:153-162.
6. da Silva J.G., Hyppolito M.A., de Oliveira J.A.A., Corrado A.P., Itoa I.Y., Carvalho Y. Aminoglycoside antibiotic derivatives: preparation and evaluation of toxicity on cochlea and vestibular tissues and antimicrobial activity. Bioorg. Med. Chem. 2007, 15:3624-3634.
7. Silverblatt F.J., Kuehn C. Autoradiography of gentamicin uptake by the rat proximal tubule cell. Kidney Int. 1979, 15:335-345.
8. Dulon D., Hiel H., Aurousseau C., Erre J.P., Aran J.M. Pharmacokinetics of gentamicin in the sensory hair cells of the organ of Corti: rapid uptake and long term persistence. C. R. Acad. Sci. Paris III 1993, 316:682-687.
9. Mingeot-Leclercq M.P., Tulkens P.M. Aminoglycosides: nephrotoxicity. Antimicrob. Agents Chemother. 1999, 43:1003-1012.
10. Servais H., van der Smissen P., Thirion G., van der Essen G., van Bambeke F., Tulkens P.M., Mingeot-Leclercq M.P. Gentamicin-induced apoptosis in LLC-PK1 cells: involvement of lysosomes and mitochondria. Toxicol. Appl. Pharmacol. 2005, 206:321-333.
11. Servais H., Ortiz A., Devuyst O., Denamur S., Tulkens P.M., Mingeot-Leclercq M.P. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis 2008, 13:11-32.
12. Ding D., Jiangc H., Salvi R.J. Mechanisms of rapid sensory hair-cell death following co-administration of gentamicin and ethacrynic acid. Hear. Res. 2010, 259:16-23.
13. Vital Brazil O., Prado-Franceschi J. The nature of neuromuscular block produced by neomycin and gentamicin. Arch. Int. Pharmacodyn. Ther. 1969, 179:78-85.
14. Prado W.A., Corrado A.P., Marseillan R.F. Competitive antagonism between calcium and antibiotics at the neuromuscular junction. Arch. Int. Pharmacodyn. Ther. 1978, 231:297-307.
15. Ohmori H. Mechanoelectrical transduction currents in isolated vestibular hair cells of the chick. J. Physiol. 1985, 359:189-217.
16. Kroese A.B.A., Das A., Hudspeth A.J. Blockage of the transduction channels of hair cells in the bullfrog's sacculus by aminoglycoside antibiotics. Hear. Res. 1989, 37:203-218.
17. Winegar B.D., Haws C.M., Lansman J.B. Subconductance block of single mechanosensitive ion channels in skeletal muscle fibers by aminoglycoside antibiotics. J. Gen. Physiol. 1996, 107:433-443.
18. Lin X., Hume R.I., Nuttall A.L. Voltage-dependent block by neomycin of the ATPinduced whole cell current in guinea pig outer hair cells. J. Neurophysiol. 1993, 70:1593-1605.
19. Okamoto T., Sumikawa K. Antibiotics cause changes in the desensitization of ACh receptors expressed in Xenopus oocytes. Brain Res. Mol. Brain Res. 1991, 9:165-168.
20. Nishizaki T., Morales A., Gehle V.M., Sumikawa K. Differential interactions of gentamicin with mouse junctional and extrajunctional ACh receptors expressed in Xenopus oocytes. Brain Res. Mol. Brain Res. 1994, 21:99-106.
21. 2+ entry at the cholinergic receptor. J. Physiol. 2000, 525:641-654.
22. Myrdal S.E., Styger P.S. TRPV1 regulators mediate gentamicin penetration of cultured kidney cells. Hear. Res. 2005, 204:170-182.
23. Georgiev G.D., Georgiev A.S., Lalchev Z. Interaction of gentamicin with phosphatidylserine/phosphatidylcholine mixtures in adsorption monolayers and thin liquid films: morphology and thermodynamic properties. Eur. Biophys. J. 2010, 39:1301-1312.
24. Barbault F., Ren B., Rebehmed J., Teixeira C., Luo Y., Smila-Castro O., Maurel F., Tao Fan B., Zhang L., Zhang L. Flexible computational docking studies of new aminoglycosides targeting RNA 16S bacterial ribosome site. Eur. J. Med. Chem. 2008, 43:1648-1656.
25. Walter F., Vicens Q., Westhof E. Aminoglycoside RNA interactions. Curr. Opin. Chem. Biol. 1999, 3:694-704.
26. P. Dunant, Strategies for molecular therapy of Duchenne muscular dystrophy, Ph.D. Thesis from Fakultät für Chemie und Pharmazie der Ludwig-Maximilians-Universität München (2003).
27. Howard M.T., Shirts B.H., Petros L.M., Flanigan K.M., Gesteland R.F., Atkins J.F. Sequence specificity of aminoglycoside-induced stop codon readthrough: potential implications for treatment of Duchenne muscular dystrophy. Ann. Neurol. 2000, 48:164-169.
28. Luedtke N.W., Liu Q., Tor Y. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element. Biochemistry 2003, 42:11391-11403.
29. Wang Y., Hamasaki K., Rando R.R. Specificity of aminoglycoside binding to RNA constructs derived from the 16SrRNA decoding region and the HIV-RRE activator region. Biochemistry 1997, 36:768-779.
30. Brun C., Suter D., Pauli C., Dunant P., Lochmüller H., Burgunder J.M., Schümperli D., Weis J. U7 snRNAs induce correction of mutated dystrophin pre-mRNA by exon skipping. Cell. Mol. Life Sci. 2003, 60:557-566.
31. Dunant P., Walter M.C., Karpati G., Lochmüller H. Gentamicin fails to increase dystrophin expression in dystrophin-deficient muscle. Muscle Nerve 2003, 27:624-627.
32. Mingeot-Leclercq M.P., Schanck A., Ronveaux-Dupal M.F., Deleers M., Brasseur R., Ruysschaert J.M., Laurent G., Tulkens P.M. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers. Biochem. Pharmacol. 1989, 38:729-741.
33. van Bambeke F., Tulkens P.M., Brasseur R., Mingeot-Leclercq M.P. Aminoglycoside antibiotics induce aggregation but not fusion of negatively-charged liposomes. Eur. J. Pharmacol. 1995, 289:321-333.
34. Lakowicz J.R. Principles of Fluorescence Spectroscopy 1999, 185-210. Kluwer Academic/Plenum Publishers, New York.
35. Corey D.P., Hudspeth A.J. Kinetics of the receptor current in bullfrog saccular hair cells. J. Neurosci. 1983, 3:962-976.
36. Nauli S.M., Zhou J. Polycistins and mechanosensation in renal and nodal cilia. Bioessays 2004, 26:844-856.
37. Aramaki Y., Tsuchiya S. Interactions between aminoglycosides and phospholipids using liposomes: a possible mechanism of nephrotoxicity. Pharm. Res. 1989, 6:362-366.
38. Kishore B.K., Kállay Z., Lambricht G., Laurent G., Tulkens P.M. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds and displaces gentamicin from negatively-charged phospholipid layers. J. Pharmacol. Exp. Ther. 1990, 255:867-873.
39. Eisenberg E.S., Mandel L.J., Kaback H.R., Miller M.H. Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus. J. Bacteriol. 1984, 157:863-867.
40. Mates S.M., Eisenberg E.S., Mandel L.J., Patel L., Kaback H.R., Miller M.H. Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:6693-6697.
41. Marcotti W., van Netten S.M., Kros C.J. The aminoglycoside antibiotic dihydrostreptomycin rapidly enters mouse outer hair cells through the mechano-electrical transducer channels. J. Physiol. 2005, 567:505-521.
42. Kohlhepp S.J., Hou L., Gilbert D.N. Pig kidney (llc-pk1) cell membrane fluidity during exposure to gentamicin or tobramycin. Antimicrob. Agents Chemother. 1994, 38:2169-2171.
43. Dai C.F., Mangiardi D., Cotanche D.A., Steyger P.S. Uptake of fluorescent gentamicin by vertebrate sensory cells in vivo. Hear. Res. 2006, 213:64-78.
44. Schacht J. Molecular mechanisms of drug-induced hearing loss. Hear. Res. 1986, 22:297-304.
45. Williams S.E., Zenner H.P., Schacht J. Three molecular steps of aminoglycoside ototoxicity demonstrated in outer hair cells. Hear. Res. 1987, 30:11-18.
46. Forge A., Zajic G., Davies S., Weiner N., Schacht J. Gentamicin alters membrane structure as shown by freeze-fracture of liposomes. Hear. Res. 1989, 37:129-139.
47. Alharazneh A., Luk L., Huth M., Monfared A., Steyger P.S., Cheng A.G., Ricci A.J. Functional hair cell mechanotransducer channels are required for aminoglycoside ototoxicity. PLoS One 2011, 6. (Article number e22347).